885 related articles for article (PubMed ID: 7772727)
21. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers.
Tsukasaki K; Miller CW; Kubota T; Takeuchi S; Fujimoto T; Ikeda S; Tomonaga M; Koeffler HP
Cancer Res; 2001 May; 61(9):3770-4. PubMed ID: 11325850
[TBL] [Abstract][Full Text] [Related]
22. [Confirmation of the presence in Cuba of human T-cell lymphotropic virus type I using the polymerase chain reaction].
Rolo Gómez F; De Armas MB; Mato Luis J; Lubián Caballero AL; Díaz Torres H
Rev Cubana Med Trop; 1997; 49(3):204-8. PubMed ID: 9685988
[TBL] [Abstract][Full Text] [Related]
23. [Natural history of HTLV-I infection].
Yamaguchi K
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):770-4. PubMed ID: 1630039
[TBL] [Abstract][Full Text] [Related]
24. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
[TBL] [Abstract][Full Text] [Related]
25. A rapid method for determination of the relative copy number of HTLV-I proviral genome in HTLV-I carriers and adult T-cell leukemia patients by polymerase chain reaction.
Hori T; Kikuchi H; Ohtsuka E; Ono K; Saburi Y; Nasu M
Haematologia (Budap); 1999; 29(4):265-76. PubMed ID: 10438066
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of antibodies to human T-cell leukemia/lymphoma virus type I and human immunodeficiency virus in Japanese immigrant colonies in Bolivia and Bolivian natives.
Ohtsu T; Tsugane S; Tobinai K; Shimoyama M; Nanri S; Watanabe S
Jpn J Cancer Res; 1987 Dec; 78(12):1347-53. PubMed ID: 2892821
[TBL] [Abstract][Full Text] [Related]
27. [Epidemiology of HTLV-I carriers in Hirado Island and virological and immunological investigation of HTLV-I associated pulmonary disease].
Kohno S; Higashiyama Y; Mukae H; Morikawa N; Kadota J; Koga H; Hara K; Ikeda S; Tomonaga M; Katamine S
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):763-9. PubMed ID: 1630038
[TBL] [Abstract][Full Text] [Related]
28. [Difference of antibody profile for human T-lymphotropic virus type-I (HTLV-I) among individuals].
Kamihira S; Sohda H; Momita S; Amagasaki T; Yamada Y; Ikeda S; Tomonaga M; Ichimaru M; Kinosita K; Sawada T
Rinsho Ketsueki; 1989 Jun; 30(6):823-9. PubMed ID: 2795893
[TBL] [Abstract][Full Text] [Related]
29. [The T- and B-cell malignancy Study Group: The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan--estimates of risk of ATL and its geographical and clinical features].
Gan No Rinsho; 1990 Feb; Spec No():431-41. PubMed ID: 2179598
[No Abstract] [Full Text] [Related]
30. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection.
Manns A; Miley WJ; Wilks RJ; Morgan OS; Hanchard B; Wharfe G; Cranston B; Maloney E; Welles SL; Blattner WA; Waters D
J Infect Dis; 1999 Nov; 180(5):1487-93. PubMed ID: 10515807
[TBL] [Abstract][Full Text] [Related]
31. Isolation of HTLV-1 from an aggressive form of ATL in a Romanian patient not at risk of infection and with seronegative family members.
Manca N; Ferremi P; De Simone N; Pirali F; Turano A
New Microbiol; 1997 Jul; 20(3):177-85. PubMed ID: 9258936
[TBL] [Abstract][Full Text] [Related]
32. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.
Satake M; Yamaguchi K; Tadokoro K
J Med Virol; 2012 Feb; 84(2):327-35. PubMed ID: 22170555
[TBL] [Abstract][Full Text] [Related]
33. Adult T-cell leukemia.
Takatsuki K
Intern Med; 1995 Oct; 34(10):947-52. PubMed ID: 8563094
[TBL] [Abstract][Full Text] [Related]
34. Human T-cell lymphotropic virus type 1 (HTLV-1) and lymphoid malignancies in Dominica: a seroprevalence study.
Adedayo OA; Shehu SM
Am J Hematol; 2004 Dec; 77(4):336-9. PubMed ID: 15551358
[TBL] [Abstract][Full Text] [Related]
35. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
[TBL] [Abstract][Full Text] [Related]
36. HTLV-I seroprevalence in patients with undefined uveitis in central Japan.
Goto K; Saeki K; Kurita M; Iijima Y; Miyake A; Ohno S
Jpn J Ophthalmol; 1994; 38(2):175-7. PubMed ID: 7967209
[TBL] [Abstract][Full Text] [Related]
37. Antibody to the human T-lymphotropic virus type 1 (HTLV-1) envelope protein Gp46 in patients co-infected with HCV and HTLV-1.
Takeoka H; Furusyo N; Toyoda K; Murata M; Sagara Y; Kashiwagi S; Hayashi J
Am J Trop Med Hyg; 2007 Jul; 77(1):192-6. PubMed ID: 17620653
[TBL] [Abstract][Full Text] [Related]
38. Adult T-cell leukemia in Japan.
Takatsuki K; Matsuoka M; Yamaguchi K
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S15-9. PubMed ID: 8797698
[TBL] [Abstract][Full Text] [Related]
39. The seroprevalence of anti-HTLV-1 antibodies in patients with various liver diseases.
Iida S; Fujiyama S; Yoshida K; Morishita T; Shibata J; Sato T; Nishimura Y
Hepatogastroenterology; 1988 Oct; 35(5):242-4. PubMed ID: 3229734
[TBL] [Abstract][Full Text] [Related]
40. Human T-lymphotropic virus type I (HTLV-I) and adult T-cell leukemia (ATL) are endemic to southwestern Japan.
Miyazaki K; Yamaguchi K; Takatsuki K; Fujisaki S; Okamura H
Gynecol Oncol; 1990 May; 37(2):306. PubMed ID: 2344977
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
